Chesapeake Research Group

Chesapeake Research Group is a multi-specialty clinical research site and contract research organization (CRO) based in Columbia, Maryland. Founded in 1994, the company specializes in conducting Phase I-IV clinical trials for the pharmaceutical, biotechnology, and medical device industries. Their expertise spans a wide range of therapeutic areas, including neurology, psychiatry, internal medicine, and pain management. In 2021, the company was acquired by CenExel, integrating into a larger national network of premier clinical research sites. The facility is recognized for its high-quality data management and robust patient recruitment capabilities.